Matches in DBpedia 2016-04 for { <http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm> ?p ?o }
Showing triples 1 to 16 of
16
with 100 triples per page.
- ucm256581.htm accessdate "2011-06-09".
- ucm256581.htm accessdate "2013-01-15".
- ucm256581.htm accessdate "2015-11-05".
- ucm256581.htm date "2011-06-08".
- ucm256581.htm first "Center for Drug Evaluation and".
- ucm256581.htm isCitedBy Amlodipine.
- ucm256581.htm isCitedBy Simvastatin.
- ucm256581.htm last "Research".
- ucm256581.htm publisher "Federal Drug Administration".
- ucm256581.htm publisher "U.S. Food and Drug Administration".
- ucm256581.htm quote "The U.S. Food and Drug Administration is recommending limiting the use of the highest approved dose of the cholesterol-lowering medication, simvastatin because of increased risk of muscle damage.".
- ucm256581.htm title "Drug Safety and Availability - FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor to reduce the risk of muscle injury".
- ucm256581.htm title "FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor to reduce the risk of muscle injury".
- ucm256581.htm url ucm256581.htm.
- ucm256581.htm url "http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm".
- ucm256581.htm website "www.fda.gov".